SpinaFX Medical Archives - Medical Design Sourcing

SpinaFX Medical names chief operating officer

SpinaFX Medical today announced that it has appointed John Soloninka as chief operating officer.

Soloninka joins the minimally invasive image-guided therapy startup with more than 20 years of experience in health tech companies. Prior to joining the company, he was CEO and cofounder of a $28 million public/private venture debt fund where he oversaw a syndicated $86 million investment in 36 early-stage health tech companies like Synaptive Medical, Conavi, Spartan and Profound Medical.

“John brings an incredible combination of personal characteristics, skills, relevant expertise and strategic insights. His professional training, discipline, and entrepreneurial approach to business is invaluable to SpinaFX’s early-stage commercialization and growth. I am extremely pleased John as chosen to join us,” CEO Jeff Cambra said in a news release.

Soloninka has also cofounded an AI-based oncology management company that was acquired by Varian Medic…

Former Medtronic and Zimmer-Biomet VP joins back pain startup as CEO

Jeff Cambra, CEO of SpinaFX [Photo courtesy of SpinaFX]Jeff Cambra is the new CEO of SpinaFX Medical, the back pain therapy startup said on October 1.

Cambra was previously a vice president at Zimmer Biomet (NYSE:ZBH), “leading product management for their $5 billion global reconstruction business,” SpinaFX said in a news release. He served in that role from November 2020 to June 2021, according to his LinkedIn page.

He ended a nearly 11-year career at Medtronic (NYSE:MDT) in 2020, ultimately serving as vice president and general manager of interventional therapies. SpinaFX said he “led a successful turnaround of their $400 million vertebral augmentation and oncology business through new technology innovation, strategic partnerships, acquisitions and expanding margins.”

Get the full story at our sister site Medical Design & Outsourcing.

Former Medtronic and Zimmer-Biomet VP joins back pain startup as CEO

Jeff Cambra, CEO of SpinaFX [Photo courtesy of SpinaFX]

Jeff Cambra is the new CEO of SpinaFX Medical, the back pain therapy startup said on Friday.

Cambra was previously a vice president at Zimmer Biomet (NYSE:ZBH), “leading product management for their $5 billion global reconstruction business,” SpinaFX said in a news release. He served in that role from November 2020 to June 2021, according to his LinkedIn page.

He ended a nearly 11-year career at Medtronic (NYSE:MDT) in 2020, ultimately serving as vice president and general manager of interventional therapies. SpinaFX said he “led a successful turnaround of their $400 million vertebral augmentation and oncology business through new technology innovation, strategic partnerships, acquisitions and expanding margins.”

“With my passion for the interventional space, I constantly assess and monitor multiple promising technologies, I recognized the br…